The purpose of this RFA is to stimulate the development of high-quality, innovative cancer research projects that will move forward to nationally-funded grant awards. Idea awards provide early funding support for high-risk, high-payoff research for which external grants are difficult to obtain.
HCC leadership anticipates distributing awards of up to $50,000 for one year without the option to renew. Awardees are required to submit a timeline showing when an NCI R01 equivalent grant will be submitted. In addition, a final progress report is required upon project completion including an outline of project results and grant applications submitted and/or planned for submission. PIs are expected to seek regulatory [e.g., IACUC, IRB] approvals in a timely manner. Any extensions will require prior approval. Please note that the funding cannot be released until all applicable human and animal subject protocols have been approved and copies have been sent to Diane Wallace at email@example.com. All publications derived from this funding must site the HCC's Cancer Center Support Grant (P30 CA138313).
Full applications are due by 5:00pm on Friday, August 3rd, 2018. Please send one PDF file of the application packet via email to Kimrey Lloyd (firstname.lastname@example.org). Applications will be peer-reviewed by mid-September. Notifications of awards will be made in early October, 2018. The earliest anticipated start date is November 1, 2018, depending on the status of human and animal studies protocol approvals.
Each full application will be assigned to both internal and external reviewers who have substantial expertise in cancer research and in reviewing grants.
Review criteria will include:
Applicants are strongly encouraged to consult HCC BSR Biostatisticians when developing the research design and methods of their proposals (Dr. Betsy Hill, Director, BSR).